Publications:

---

Nanomedicine Strategies for Management of Drug Resistance in Lung Cancer.

International Journal Of Molecular Sciences

Haider, Mohamed M; Elsherbeny, Amr A; Pittalà, Valeria V; Consoli, Valeria V; Alghamdi, Maha Ali MA; Hussain, Zahid Z; Khoder, Ghalia G; Greish, Khaled K

Publication Date: 2022-02-06

Variant appearance in text: PI3K: H1047K

PubMed Link: 35163777

Variant Present in the following documents:

• Main text
• ijms-23-01853.pdf

View BVdb publication page

---

Nanomedicine Strategies for Management of Drug Resistance in Lung Cancer.

International Journal Of Molecular Sciences

Haider, Mohamed M; Elsherbeny, Amr A; Pittalà, Valeria V; Consoli, Valeria V; Alghamdi, Maha Ali MA; Hussain, Zahid Z; Khoder, Ghalia G; Greish, Khaled K

Publication Date: 2022-02-06

Variant appearance in text: PI3K: H1047K

PubMed Link: 35163777

Variant Present in the following documents:

• Main text
• ijms-23-01853.pdf

View BVdb publication page

---

Long-term disease control and survival observed after stereotactic ablative body radiotherapy for oligometastatic breast cancer.

Cancer Medicine

Wijetunga, N Ari NA; Dos Anjos, Carlos H CH; Zhi, W Iris WI; Robson, Mark M; Tsai, C Jillian CJ; Yamada, Yoshiya Y; Dover, Laura L; Gillespie, Erin F EF; Xu, Amy J AJ; Yang, Jonathan T JT

Publication Date: 2021-08

Variant appearance in text: PIK3CA: H1047K

PubMed Link: 34159748

Variant Present in the following documents:

• Main text
• CAM4-10-5163.pdf

View BVdb publication page

---

Genotype correlates with clinical severity in PIK3CA-associated lymphatic malformations.

Jci Insight

Zenner, Kaitlyn K; Cheng, Chi Vicky CV; Jensen, Dana M DM; Timms, Andrew E AE; Shivaram, Giridhar G; Bly, Randall R; Ganti, Sheila S; Whitlock, Kathryn B KB; Dobyns, William B WB; Perkins, Jonathan J; Bennett, James T JT

Publication Date: 2019-11-01

Variant appearance in text: PIK3CA: His1047Lys

PubMed Link: 31536475

Variant Present in the following documents:

• Main text

View BVdb publication page

---

Targeting AKT1-E17K and the PI3K/AKT Pathway with an Allosteric AKT Inhibitor, ARQ 092.

Plos One

Yu, Yi Y; Savage, Ronald E RE; Eathiraj, Sudharshan S; Meade, Justin J; Wick, Michael J MJ; Hall, Terence T; Abbadessa, Giovanni G; Schwartz, Brian B

Publication Date: 2015

Variant appearance in text: PIK3CA: H1047K

PubMed Link: 26469692

Variant Present in the following documents:

• Main text
• pone.0140479.pdf

View BVdb publication page

---

Prevalence of PIK3CA mutations and the SNP rs17849079 in Arab breast cancer patients.

Cancer Biology & Therapy

Karakas, Bedri B; Colak, Dilek D; Kaya, Namik N; Ghebeh, Hazem H; Al-Qasem, Abeer A; Hendrayani, Fawziah F; Toulimat, Mohamed M; Al-Tweigeri, Taher T; Park, Ben Ho BH; Aboussekhra, Abdelilah A

Publication Date: 2013-10-01

Variant appearance in text: PIK3CA: His1047Lys

PubMed Link: 23982433

Variant Present in the following documents:

• Main text

View BVdb publication page

---

Chemical interrogation of FOXO3a nuclear translocation identifies potent and selective inhibitors of phosphoinositide 3-kinases.

The Journal Of Biological Chemistry

Link, Wolfgang W; Oyarzabal, Julen J; Serelde, Beatriz G BG; Albarran, Maria Isabel MI; Rabal, Obdulia O; Cebriá, Antonio A; Alfonso, Patricia P; Fominaya, Jesus J; Renner, Oliver O; Peregrina, Sandra S; Soilán, David D; Ceballos, Plácido A PA; Hernández, Ana-Isabel AI; Lorenzo, Milagros M; Pevarello, Paolo P; Granda, Teresa G TG; Kurz, Guido G; Carnero, Amancio A; Bischoff, James R JR

Publication Date: 2009-10-09

Variant appearance in text: PI3K: H1047K

PubMed Link: 19690175

Variant Present in the following documents:

• Main text

View BVdb publication page

---